Lopez-Sublet, M <br/><br/>
Limbic encephalitis and type 1 diabetes with glutamic acid decarboxylase 65 (GAD65) autoimmunity: improvement with high-dose intravenous immunoglobulin therapy.  [electronic resource] 

 -  Diabetes & metabolism  Jun 2012 
 - 273-5 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1878-1780 
<br/><br/><label>Standard No.: </label>10.1016/j.diabet.2012.02.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Autoimmunity<br/>Diabetes Mellitus, Type 1--complications<br/>Female<br/>Glutamate Decarboxylase--immunology<br/>Humans<br/>Immunization, Passive--methods<br/>Immunoglobulins, Intravenous--administration & dosage<br/>Immunosuppressive Agents--therapeutic use<br/>Limbic Encephalitis--drug therapy<br/>Magnetic Resonance Imaging<br/>Neuropsychological Tests<br/>Treatment Outcome